Clover Health Investments (NASDAQ:CLOV) Insider Sells 19,275 Shares of Company Stock

Clover Health Investments, Corp. (NASDAQ:CLOV) insider Karen Soares sold 19,275 shares of the firm’s stock in a transaction on Tuesday, October 20th. The shares were sold at an average price of $4.66, for a total value of $89,821.50. Following the sale, the insider directly owned 1,573,423 shares of the company’s stock, valued at approximately $7,332,151.18. This represents a 1.21% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Karen Soares also recently made the following trade(s):

• On Thursday, October 15th, Karen Soares sold 14,673 shares of Clover Health Investments stock. The stock was sold at an average price of $4.68, for a total transaction of $68,669.64.
• On Tuesday, September 15th, Karen Soares sold 6,846 shares of Clover Health Investments stock. The stock was sold at an average price of $4.78, for a total transaction of $32,723.88.

Clover Health Investments Stock Up 8.1%

CLOV traded up $0.36 during trading on Tuesday, hitting $4.80. 3,495,271 shares of the company traded hands, compared to its average volume of 5,913,673. The firm has a market cap of $2.55 billion, a P/E ratio of -95.98 and a beta of 2.45. The stock’s fifty day moving average is $4.45 and its 200 day moving average is $4.03. Clover Health Investments, Corp. has a one year low of $1.58 and a one year high of $5.59.

Clover Health Investments (NASDAQ:CLOV) last posted its quarterly earnings data on Wednesday, August 5th. The company reported $0.05 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.04 by $0.01. The business had revenue of $743.17 million during the quarter, compared to the consensus estimate of $728.27 million. Clover Health Investments had a negative net margin of 0.74% and a negative return on equity of 4.20%. On average, equities research analysts forecast that Clover Health Investments, Corp. will post 0.06 EPS for the current fiscal year.

Analysts Set New Price Targets

Several equities analysts recently commented on the company. UBS Group upped their price objective on Clover Health Investments from $4.75 to $5.00 and gave the company a “neutral” rating in a research note on Thursday, August 6th. Wall Street Zen lowered Clover Health Investments from a “strong-buy” rating to a “buy” rating in a research note on Sunday, August 16th. Deutsche Bank Aktiengesellschaft began coverage on Clover Health Investments in a research report on Thursday, September 10th. They set a “buy” rating and a $6.00 price target on the stock. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Clover Health Investments in a research report on Monday, September 21st. Finally, Canaccord Genuity Group increased their price target on Clover Health Investments from $4.20 to $5.50 and gave the stock a “buy” rating in a research note on Tuesday, July 21st. Two analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $4.75.

Institutional Investors Weigh In On Clover Health Investments

Hedge funds and other institutional investors have recently bought and sold shares of the business. Tidal Investments LLC bought a new position in Clover Health Investments in the 2nd quarter worth about $2,156,000. Bank of New York Mellon Corp purchased a new stake in shares of Clover Health Investments in the second quarter worth about $6,346,000. WINTON GROUP Ltd bought a new position in shares of Clover Health Investments in the second quarter valued at approximately $913,000. Lazard Asset Management LLC bought a new position in shares of Clover Health Investments in the first quarter valued at approximately $309,000. Finally, AXQ Capital LP boosted its position in shares of Clover Health Investments by 602.6% in the second quarter. AXQ Capital LP now owns 146,569 shares of the company’s stock valued at $768,000 after acquiring an additional 125,708 shares during the period. Institutional investors own 19.77% of the company’s stock.

More Clover Health Investments News

Here are the key news stories impacting Clover Health Investments this week:

• Positive Sentiment: Clover Health earned top distinctions in U.S. News & World Report’s 2027 Medicare Advantage ratings across New Jersey, Georgia, and South Carolina. The recognition may strengthen the company’s brand, support member growth, and improve investor sentiment regarding its insurance operations. Clover Health Earns Top Honors in U.S. News & World Report’s 2027 Medicare Advantage Ratings Across Three States
• Positive Sentiment: Recent institutional activity was generally favorable. Bank of New York Mellon, Tidal Investments, and Winton Group initiated positions, while California State Teachers’ Retirement System and AXQ Capital increased their holdings. Such buying can reinforce confidence in CLOV’s longer-term outlook.
• Positive Sentiment: Analyst coverage includes Deutsche Bank’s “buy” rating and a $6.00 price target, above recent trading levels. Clover’s latest reported quarter also exceeded expectations for both earnings and revenue, although profitability remains limited.
• Neutral Sentiment: Analyst opinion remains mixed: the consensus rating is “Hold,” with two Buy, three Hold, and one Sell rating and an average price target of $4.75. This suggests optimism is present but not broad-based.
• Negative Sentiment: CEO Andrew Toy, CEO Conrad Wai, and insider Karen Soares sold shares at $4.68. The transactions were conducted under pre-arranged Rule 10b5-1 plans to cover tax withholding on vested equity awards, and each insider retained a substantial stake, reducing the significance of the sales as a bearish signal. Clover Health Investments Insider Karen Soares Sells Shares

About Clover Health Investments

Clover Health Investments, Corp. is a health insurance technology company focused on providing Medicare Advantage plans to eligible seniors in the United States. Its plans combine hospital, medical and prescription drug coverage with additional benefits that may vary by plan and location.

The company uses its Clover Assistant technology platform to provide physicians with data-driven insights intended to support clinical decision-making and care coordination. The platform aggregates member health information and helps participating providers identify care opportunities, manage chronic conditions and engage with patients.

Clover Health was founded in 2012 and became a publicly traded company in 2021 through a merger with a special purpose acquisition company.